IL2 and myeloid sarcoma: Increased production of IL-2 promotes immunological tolerance and ameliorates autoimmunity by stimulating T regs growth and survival [32–35], while more IL-4 and IL-5 indicates a shift towards a Th2 phenotype, which is immunosuppressive in MS and EAE [21].